Evidence map›Paper›PMID 33117641›Full record

ArticlePreventive medicine reports2020

Hereditary colorectal cancer screening: A 10-year longitudinal cohort study following an educational intervention.

June C Carroll, Joanne A Permaul, Kara Semotiuk, Eric M Yung, Sean Blaine, Elizabeth Dicks, Ellen Warner, Heidi Rothenmund, Mary Jane Esplen, Rahim Moineddin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

June C CarrollRay D. Wolfe Department of Family Medicine, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
Joanne A PermaulRay D. Wolfe Department of Family Medicine, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
Kara SemotiukZane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.
Eric M YungDepartment of Anesthesia, University of Toronto, Toronto, Ontario, Canada.
Sean BlaineDepartment of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Elizabeth DicksCraig L. Dobbin Centre for Genetics Research, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Ellen WarnerOdette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Heidi RothenmundWinnipeg Regional Health Authority, Winnipeg, Manitoba, Canada.
Mary Jane EsplenDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Rahim MoineddinDepartment of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
John McLaughlinDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CAMount Sinai Hospital · CAMemorial University of Newfoundland · CASunnybrook Health Science Centre · CAWinnipeg Regional Health Authority · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Family history (FH) of a first-degree relative with colorectal cancer (CRC) is associated with two to fourfold increased risk, yet screening uptake is suboptimal despite proven mortality reduction. We developed a FH-based CRC Risk Triage/Management tool for family physicians (FPs), and educational booklet for patients with CRC FH. This report describes physician referral and patient screening behavior 5 and 10 years post-educational intervention, and factors associated with screening. Longitudinal cohort study. FPs/patients in Ontario and Newfoundland, Canada were sent questionnaires at baseline (2005), 5 and 10 years (2015) following tool/booklet receipt. FPs were asked about CRC screening, patients about FH, screening type and timing. "Correct" screening was concordance with tool recommendations. Results reported for 29/121 (24%) FPs and 98/297 (33%) patients who completed all 3 questionnaires. Over 10 years 2/3 patients received the correct CRC screening test at appropriate timing (baseline 75%, 5-year 62%, 10-year 65%). About half reported their FP recommended CRC screening (5-year 51%, 10-year 63%). Fewer than half the patients correctly assessed their CRC risk (44%, 40%, 41%). Patients were less likely to have correct screening timing if female (RR 0.78; 95% CI 0.61, 0.99; p = 0.045). Patients were less likely to have both correct test and timing if moderate/high CRC risk (RR 0.66; 95% CI 0.47, 0.93; p = 0.017) and more likely if their physician recommended screening (RR1.69; 95% CI 1.15, 2.49; p = 0.007). Physician discussion of CRC risk and screening can positively impact patient screening behavior. Efforts are particularly needed for women and patients at moderate/high CRC risk.

Indexed as

Cancer: screeningColorectal cancerFamily historyFamily physician

Identifiers

PMID33117641
PMCPMC7581973
OpenAlexW3089013620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.